Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Social value and meaningful outcomes in clinical trials research S. Pocock, London (UK)Value of fixed combination treatments in hypertensive patients with comorbidities J.-J. Mourad, Paris (FR)Environmental hazards – air pollution and noise as novel risk factors T. Gori, Mainz (DE)Recommendations for sports participation in athletes with known cardiovascular disease D. Corrado, Padov (IT)
“Paracelsus reloaded” – searching for the perfect “dose” of physical activity S. Sharma, London (UK)Bariatric surgery in obesity and type 2 diabetes E. Osto, Zurich (CH)NOACs in AF patients undergoing cardioversion: Overview and latest data A.J. Camm, London (UK)
HDL-Cholesterol – an enigma? U. Landmesser, Berlin (DE)Heart rate reduction in angina and heart failure: a paradox? K. Swedberg, Gothenburg (SE)Differential imaging: How to select the right tool for the patient’s problem? J.J. Bax, Leiden (NL)Hybrid imaging O. Gämperli, Zurich (CH)Diagnosis of thrombosis and pulmonary embolism H. Bounameaux, Geneva (CH)ESC Guidelines on pulmonary embolism: recommendations and patient management A. Torbicki, Warszawa (PL)Thrombosis and Pulmonary Embolism: Implementing the New Guidelines - Cases: A. Torbicki, Warszawa (PL)Ablation of Ventricular Tachycardias: When and How? - Cases: L. Haegeli, Zurich (CH) Ventricular tachycardia: drugs versus devices A.J. Camm, London (UK)Role of catheter ablation for the management of VT H. Calkins, Baltimore (US)Pathophysiology of PH – the right heart matters R. Naeije, Brussels (BE)Therapeutic approaches in PH and the new ESC Guidelines J.-L. Vachiery, Brussels (BE)Medical management of cardiac patients during non-cardiac surgery D. Spahn, Zurich (CH)
Critical appraisal of AF management guidelines across the Atlantic H. Calkins, Baltimore (US)Curative treatment of AF: too far to reach? G. Hindricks, Leipzig (DE)Risk stratification in the elderly with AF: therapeutic implications D. Atar, Oslo (NO)Genetics of cardiomyopathies P. Elliott, London (UK)The new ESC Guidelines on hypertrophic cardiomyopathy P. Elliott, London (UK)Is FFR essential to guide PCI? W. Wijns, Aalst (NL)Cardiomyopathies, sudden death -Cases: C. Gruner, Zurich (CH)What is a Significant Coronary Stenosis? Coronary Flow and Pressure Measurement as a Guide - Cases: K. Weber, Winterthur The role of imaging in catheter-based procedures J.J. Bax, Leiden (NL)Early diagnosis of acute MI: novel strategies C. Müller, Basel (CH)Mechanisms of ACS: the clinical perspective F. Crea, Rome (IT)Update on prasugrel – optimising therapy after ACS/PCI C. Kaiser, Basel (CH)
Sleep apnoea and heart failure P. Ponikowski, Wroclaw (PL)Telemonitoring in heart failure: IN-TIME and beyond G. Hindricks, Leipzig (DE)Devices in Heart Failure - Cases: E. Holy, Zurich (CH) Early management of acute HF: Time is also muscle G. Filippatos, Athens (GR)
Zurich Heart HouseFoundation for Cardiovascular ResearchMoussonstrasse 4, CH-8091 Zurich, SwitzerlandPhone +41 (0) 44 250 40 83, Fax +41 (0) 44 250 40 90 Esther Willi (firstname.lastname@example.org)
Thomas F. Lüscher, Zurich, CHBertram Pitt, Ann Arbor MI, USA
Ruth Amstein, Zurich, CH
Ruth Amstein, Ph.D., Zurich, CHJeroen J. Bax, M.D., Leiden, NLPaolo G. Camici, M.D., Milan, ITFilippo Crea, M.D., Rome, ITThierry C. Gillebert, M.D., Gent, BEJohn J.P. Kastelein, M.D., Amsterdam, NLMichel Komajda, M.D., Paris, FRThomas F. Lüscher, M.D., Zurich, CHBernhard Meier, M.D., Berne, CHBertram Pitt, M.D., Ann Arbor, MI, USAKarl Swedberg, M.D., Gothenburg, SEWilliam Wijns, M.D., Ph.D., Aalst, BESalim Yusuf, M.D., Hamilton, Ontario, CA
Corinna Brunckhorst, M.D., Zurich, CHRoberto Corti, M.D., Zurich, CHFirat Duru, M.D., Zurich, CHVolkmar Falk, M.D., Zurich, CHMatthias Greutmann, M.D., Zurich, CHJohannes Holzmeister, M.D., Zurich, CHPhilipp A. Kaufmann, M.D., Zurich, CHUlf Landmesser, M.D., Zurich, CHWillibald Maier, M.D., Zurich, CHChristian Matter, M.D., Zurich, CHGeorg Noll, M.D., Zurich, CHFrank Ruschitzka, M.D., Zurich, CHChristian Schmied, M.D., Zurich, CHRudolf Speich, M.D., Zurich, CHFelix C. Tanner, M.D., Zurich, CH
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved